Apr 09, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BioMarin Pharmaceutical Inc.
BMRN, -1.62%
Today, Raymond James initiated coverage on BioMarin Pharmaceutical Inc.
BMRN, -1.62%
with a Outperform. There are 15 Buy Ratings, 4 Hold Ratings, no …
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has coverage initiated with a Outperform rating
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has coverage initiated with a Outperform rating
{$excerpt:n}